nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An executive functioning perspective in neurofibromatosis type 1: from ADHD and autism spectrum disorder to research domains
|
Smith, Taylor F. |
|
|
36 |
10 |
p. 2321-2332 |
artikel |
2 |
Ante-natal counseling in phacomatoses
|
Brabbing-Goldstein, Dana |
|
|
36 |
10 |
p. 2269-2277 |
artikel |
3 |
Clinical characterization of children and adolescents with NF1 microdeletions
|
Kehrer-Sawatzki, Hildegard |
|
|
36 |
10 |
p. 2297-2310 |
artikel |
4 |
Craniofacial bone alterations in patients with neurofibromatosis type 1
|
Chauvel-Picard, Julie |
|
|
36 |
10 |
p. 2391-2399 |
artikel |
5 |
Current status of MEK inhibitors in the treatment of plexiform neurofibromas
|
Gross, Andrea M. |
|
|
36 |
10 |
p. 2443-2452 |
artikel |
6 |
Current trends in the management of subependymal giant cell astrocytomas in tuberous sclerosis
|
Frassanito, Paolo |
|
|
36 |
10 |
p. 2527-2536 |
artikel |
7 |
Epilepsy in NF1: a systematic review of the literature
|
Bernardo, Pia |
|
|
36 |
10 |
p. 2333-2350 |
artikel |
8 |
Epilepsy surgery in tuberous sclerosis complex (TSC): emerging techniques and redefinition of treatment goals
|
Treiber, Jeffrey M. |
|
|
36 |
10 |
p. 2519-2525 |
artikel |
9 |
Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism
|
Legius, Eric |
|
|
36 |
10 |
p. 2285-2295 |
artikel |
10 |
Genetics of tuberous sclerosis complex: an update
|
Marom, Daphna |
|
|
36 |
10 |
p. 2489-2496 |
artikel |
11 |
Hemangioblastoma and von Hippel-Lindau disease: genetic background, spectrum of disease, and neurosurgical treatment
|
Klingler, Jan-Helge |
|
|
36 |
10 |
p. 2537-2552 |
artikel |
12 |
In memory of James Tait Goodrich
|
Abbott, Rick |
|
|
36 |
10 |
p. 2195 |
artikel |
13 |
Introduction to phacomatoses (neurocutaneous disorders) in childhood
|
Ruggieri, Martino |
|
|
36 |
10 |
p. 2229-2268 |
artikel |
14 |
I remember
|
Zerah, Michel |
|
|
36 |
10 |
p. 2197 |
artikel |
15 |
James Goodrich—as I knew him
|
Chatterjee, Sandip |
|
|
36 |
10 |
p. 2209-2212 |
artikel |
16 |
James Tait Goodrich 1946–2020
|
Mazza, Carlo |
|
|
36 |
10 |
p. 2201-2206 |
artikel |
17 |
James Tait Goodrich: a collector of friends
|
|
|
|
36 |
10 |
p. 2199-2200 |
artikel |
18 |
James Tait Goodrich, MD, PhD. (4/16/1946–3/30/2020)
|
Keating, Robert F. |
|
|
36 |
10 |
p. 2189-2191 |
artikel |
19 |
James Tait Goodrich, MD, PhD
|
|
|
|
36 |
10 |
p. 2207-2208 |
artikel |
20 |
James T. Goodrich, MD, PhD
|
Walker, Marion L. (Jack) |
|
|
36 |
10 |
p. 2193-2194 |
artikel |
21 |
Jim Tait Goodrich
|
Di Rocco, Concezio |
|
|
36 |
10 |
p. 2187-2188 |
artikel |
22 |
Management of spinal deformities and tibial pseudarthrosis in children with neurofibromatosis type 1 (NF-1)
|
Mladenov, Kiril V. |
|
|
36 |
10 |
p. 2409-2425 |
artikel |
23 |
Managing NF2-associated vestibular schwannomas in children and young adults: review of an institutional series regarding effects of surgery and bevacizumab on growth rates, tumor volume, and hearing quality
|
Gugel, Isabel |
|
|
36 |
10 |
p. 2471-2480 |
artikel |
24 |
Medical treatment of tuberous sclerosis-related epilepsy
|
Uliel-Sibony, Shimrit |
|
|
36 |
10 |
p. 2511-2517 |
artikel |
25 |
Neurocutaneous melanocytosis (melanosis)
|
Ruggieri, Martino |
|
|
36 |
10 |
p. 2571-2596 |
artikel |
26 |
Neurofibromatosis 1–associated optic pathway gliomas
|
Shofty, Ben |
|
|
36 |
10 |
p. 2351-2361 |
artikel |
27 |
Neurofibromatosis type 1–related hydrocephalus: causes and treatment considerations
|
Roth, Jonathan |
|
|
36 |
10 |
p. 2385-2390 |
artikel |
28 |
Neuroimaging in tuberous sclerosis complex
|
Russo, Camilla |
|
|
36 |
10 |
p. 2497-2509 |
artikel |
29 |
New treatment modalities in NF-related neuroglial tumors
|
Packer, Roger J. |
|
|
36 |
10 |
p. 2377-2384 |
artikel |
30 |
Options and strategies for hearing restoration in pediatric neurofibromatosis type 2
|
Mahboubi, Hossein |
|
|
36 |
10 |
p. 2481-2487 |
artikel |
31 |
Phacomatoses in the pediatric age group
|
Constantini, Shlomi |
|
|
36 |
10 |
p. 2227-2228 |
artikel |
32 |
Presenting symptoms in children with neurofibromatosis type 2
|
Gugel, Isabel |
|
|
36 |
10 |
p. 2463-2470 |
artikel |
33 |
Professor Wolfgang Wagner, the President of ISPN (2018–2019)
|
Wang, Kyu-Chang |
|
|
36 |
10 |
p. 2213-2219 |
artikel |
34 |
Role, function and challenges of multidisciplinary centres for rare diseases exemplified for neurofibromatosis type 1 syndrome
|
Toledano-Alhadef, Hagit |
|
|
36 |
10 |
p. 2279-2284 |
artikel |
35 |
Role of high-resolution ultrasound in detection and monitoring of peripheral nerve tumor burden in neurofibromatosis in children
|
Winter, Natalie |
|
|
36 |
10 |
p. 2427-2432 |
artikel |
36 |
Spinal manifestations of Neurofibromatosis type 1
|
Shofty, Ben |
|
|
36 |
10 |
p. 2401-2408 |
artikel |
37 |
Sturge-Weber syndrome: an update on the relevant issues for neurosurgeons
|
Bianchi, Federico |
|
|
36 |
10 |
p. 2553-2570 |
artikel |
38 |
Surgical management of peripheral nerve sheath tumours in children, with special consideration of neurofibromatoses
|
Zipfel, Julian |
|
|
36 |
10 |
p. 2433-2442 |
artikel |
39 |
The value of screening tests in children with neurofibromatosis type 1 (NF1)
|
Baudou, Eloïse |
|
|
36 |
10 |
p. 2311-2319 |
artikel |
40 |
Treatment of malignant peripheral nerve sheath tumors in pediatric NF1 disease
|
Martin, Enrico |
|
|
36 |
10 |
p. 2453-2462 |
artikel |
41 |
Visual function tests including the role of optical coherence tomography in neurofibromatosis 1
|
Mezad-Koursh, Daphna |
|
|
36 |
10 |
p. 2363-2375 |
artikel |
42 |
Why are pediatric neurosurgeons not little adult neurosurgeons?
|
Wagner, Wolfgang |
|
|
36 |
10 |
p. 2221-2225 |
artikel |